---
title: BioIVT Blog | Precision Medicine (2)
description: Precision Medicine | Learn valuable insights from the world of biotechnology and pharmaceutical research. (2)
---

*Questions? We’re here to help:*

[+1 516-483-1196](tel:+1%20516-483-1196) or [+44 1444 707333](tel:+44%201444%20707333)

[Contact Us](https://www.bioivt.com/about/contact-us)

[![BioIVT-Logo-Tag-New](https://blog.bioivt.com/hubfs/BioIVT-Logo-Tag-New.png)](https://bioivt.com)

- [BioIVT.com](https://bioivt.com/)

Search

[View My Quote](https://www.bioivt.com/?showQuoteOverlay=true)

- [Home](https://bioivt.com/)
- BioIVT Blog

## [![](https://blog.bioivt.com/hs-fs/hubfs/Imported_Blog_Media/101216.jpg?width=875&name=101216.jpg) Oct 12 2016 FFPE or Flash Frozen? Working with Human Biospecimens In Research By Samantha Bussell It’s imperative in clinical trials, exploratory studies, proof of concept analysis, and research & development to attain samples which are best suited for desired outcomes. Both processing types preserve specimens well, but which to leverage is contingent upon intended application.](https://blog.bioivt.com/ffpe-flash-frozen-working-human-biospecimens-research)

## [![](https://blog.bioivt.com/hs-fs/hubfs/Imported_Blog_Media/10616.jpg?width=875&name=10616.jpg) Oct 06 2016 MicroRNA Analysis in KRAS-Driven Tumor Growth By Samantha Bussell Research has found that KRAS mutations are present in 30 percent of non-small cell lung cancers (NSLC) and in 40 to 50 percent of colorectal cancers. This mutation prevalence has been linked to poor survival rates and chemotherapy resistance within the impacted oncology cohorts. In an attempt to remedy this known issue, researchers at University of California, San Diego screened KRAS mutant cells for synthetic lethal interactions (https://www.genomeweb.com/cancer/kras-driven-tumor-growth-inhibited-microrna). Results concluded that the miR-1298 gene when inhibited is lethal to the growth of KRAS-mutated cells, both in vitro and in vivo through a combination of microarray analyses.](https://blog.bioivt.com/microrna-analysis-kras-driven-tumor-growth)

## [![](https://blog.bioivt.com/hs-fs/hubfs/Imported_Blog_Media/92316.jpg?width=875&name=92316.jpg) Sep 23 2016 Tissue Vulnerability and Protein Characterization in Alzheimer’s Disease By Samantha Bussell Alzheimer’s disease (AD) – the most common form of dementia – is characterized by the aggregation of amyloid β (Aβ), tau in amyloid plaques, and neurofibrillary tangles that spread progressively across brain tissues. However, the mechanisms that govern selective vulnerability of specified tissues is widely debated.](https://blog.bioivt.com/tissue-vulnerability-protein-characterization-alzheimers-disease)

## [![](https://blog.bioivt.com/hs-fs/hubfs/Imported_Blog_Media/83116.jpg?width=875&name=83116.jpg) Aug 31 2016 Mutation Analysis in Cancer Research By Samantha Bussell At BioIVT, we understand the importance of mutation analysis in cancer research. Our scientists routinely perform DNA and RNA isolation from both FFPE and Fresh Frozen tissues, as well as biofluids. Additionally, we utilize PCR and FISH for the determining the presence and/or location of particular mutations within tissue specimens. Standard mutation analysis is available for lung, skin, and colon cancers, with custom mutation screens available upon request.](https://blog.bioivt.com/mutation-analysis-cancer-research)

## [![shutterstock_488099749-860x400](https://blog.bioivt.com/hs-fs/hubfs/shutterstock_488099749-860x400.jpg?width=875&name=shutterstock_488099749-860x400.jpg) Aug 15 2016 Leveraging Human Tissue for Cell Type Conversation By Lauren Vagnone Direct reprogramming of somatic cells has tremendous potential to advance applications in disease modeling, drug discovery, and gene and cell therapies. A study conducted by Duke University which depicts the plasticity of cells and their ability to “reprogram” for differing functions.](https://blog.bioivt.com/leveraging-human-tissue-cell-type-conversation)

[Previous](https://blog.bioivt.com/tag/precision-medicine/page/1) [All posts](https://blog.bioivt.com/all)

### Register for our newsletter

### Search the blog

Search

### Recent articles

### Tags

- [Uncategorized (30)](https://blog.bioivt.com/tag/uncategorized)
- [Precision Medicine (15)](https://blog.bioivt.com/tag/precision-medicine)
- [Genomics & Proteomics (11)](https://blog.bioivt.com/tag/genomics-proteomics)
- [Disease State Tissues (9)](https://blog.bioivt.com/tag/disease-state-tissues)
- [Oncology (7)](https://blog.bioivt.com/tag/oncology)

### Sign up for our newsletter

We’ll send you periodic updates about new products and services

### Questions?

You can reach us by phone, email or

[click here to contact us.](https://www.bioivt.com/about/contact-us/)

### North America, Asia Pacific

### Middle East & Africa

[516-483-1196](tel:516-483-1196) [customerservice@bioivt.com](mailto:customerservice@bioivt.com)

### Europe

[+ 44 1444 707333](tel:+%2044%201444%20707333) [cseurope@bioivt.com](mailto:cseurope@bioivt.com)

© 2024 BioIVT. BIOIVT & ELEVATING SCIENCE are registered trademarks of BioIVT LLC.

- [Trademarks](https://www.bioivt.com/trademarks)
- [Privacy Policy](https://www.bioivt.com/privacy-policy)
- [Terms and Conditions](https://www.bioivt.com/terms-and-conditions)